• Views: in the last
  • 18Week
  • 14Month
  • 131Total


  • NJ A2136
  • Requires physicians and other prescribers to obtain informed consent from parents or guardians of minors for certain medications with "black box warnings."
Introduced
(1/27/2016)
In Committee
(1/27/2016)
Crossed OverPassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This bill requires physicians, advanced practice nurses, and other authorized prescribers to obtain informed written consent from parents or legal guardians of minors prior to prescribing them psychotropic medications that are accompanied by a "black box warning." The bill specifies that in cases where written consent cannot be obtained, the prescriber must make a notation in the patient's file indicating the date and circumstances of the informed consent. The United States Food and Drug Administration (FDA) requires pharmaceutical companies to place a "black box warning" on a drug label if medical studies indicate that the drug carries a significant risk of serious or life-threatening adverse effects. A "black box warning" is the strongest warning that the FDA requires. Under the bill, a physician, advanced practice nurse, or other authorized prescriber who violates its provisions is subject to disciplinary action by the applicable State professional licensing board.
Health and Senior Services
Introduced, Referred to Assembly Health and Senior Services Committee  (on 1/27/2016)
 
 
Date Chamber Action Description
1/27/2016 A Introduced, Referred to Assembly Health and Senior Services Committee
Date Motion Yea Nay Other
None specified